Defence Therapeutics (TSE:DTC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Defence Therapeutics Inc., a Canadian biopharmaceutical company, has announced a private placement of up to $4.2 million to support its preclinical and clinical programs. The offering consists of seven million units, each comprising a common share and a warrant, aimed at advancing the company’s innovative radiopharmaceutical and ADC products.
For further insights into TSE:DTC stock, check out TipRanks’ Stock Analysis page.